---
title: "MRK.US (MRK.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MRK.US/news.md"
symbol: "MRK.US"
name: "MRK.US"
parent: "https://longbridge.com/en/quote/MRK.US.md"
datetime: "2026-05-20T01:32:57.801Z"
locales:
  - [en](https://longbridge.com/en/quote/MRK.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MRK.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MRK.US/news.md)
---

# MRK.US (MRK.US) — Related News

### [Merck ADC drug reaches primary endpoint in Phase III](https://longbridge.com/en/news/286929703.md)
*2026-05-19T14:20:35.000Z*
> Merck announced that its TROP2-targeted antibody-drug conjugate sacituzumab tirumotecan achieved dual primary endpoints 

### [ZAWYA: Merck marks World Hypertension Day with launch of Hypertension Risk Checker](https://longbridge.com/en/news/286918607.md)
*2026-05-19T13:03:36.000Z*
> Merck has launched a Hypertension Risk Checker to raise awareness about elevated resting heart rates as a potential card

### [](https://longbridge.com/en/news/286890078.md)
*2026-05-19T09:58:18.000Z*
> World Health Organization representative in Congo: Merck's Ebola vaccine Ervebo is one of the candidate vaccines availab

### [Merck's ADC cancer new drug achieves another victory, with Phase III study for endometrial cancer being a great success](https://longbridge.com/en/news/286811958.md)
*2026-05-18T19:48:55.000Z*
> Merck and Kelun-Biotech announced that their TROP2-targeted antibody-drug conjugate Sac-TMT has achieved success in the 

### [](https://longbridge.com/en/news/286786315.md)
*2026-05-18T14:20:40.000Z*
> Merck & Co. is seeking to raise approximately $6 billion through the issuance of seven bonds with varying maturities to 

### [Supreme Court rejects big pharma appeals challenging negotiated drug prices in Medicare](https://longbridge.com/en/news/286790537.md)
*2026-05-18T13:59:12.000Z*
> The US Supreme Court has rejected appeals from major drugmakers against a Medicare program that allows price negotiation